Mutational analysis and overcoming imatinib resistance in chronic myeloid leukemia with novel tyrosine kinase inhibitors. Review uri icon

Overview

publication date

  • August 1, 2007

Research

keywords

  • DNA Mutational Analysis
  • DNA, Neoplasm
  • Drug Resistance, Neoplasm
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines

Identity

Scopus Document Identifier

  • 38349081341

Digital Object Identifier (DOI)

  • 10.1007/s11864-007-0036-y

PubMed ID

  • 18157514

Additional Document Info

volume

  • 8

issue

  • 4